REVENUES

9 Months Ended

Sep. 30, 2022

REVENUES

REVENUES

NOTE 4 – REVENUES

The following table summarizes the Company’s disaggregation of revenues:

	Three Months Ended September 30,				Nine Months Ended September 30,
(U.S. dollars in thousands)	2022		2021		2022		2021
Pfizer	$	4,541	$	1,135	$	11,279	$	7,883
Brazil	$	1,708	$	3,200	$	7,162	$	4,188
Chiesi	$	2,563	$	171	$	2,781	$	189
Total revenues from selling goods	$	8,812	$	4,506	$	21,222	$	12,260
Revenues from license and R&D services	$	5,371	$	7,548	$	17,799	$	17,541